Director/PDMR Shareholding

Summary by AI BETAClose X

Applied Nutrition plc announced that Ryder Holdings Ltd, a person closely associated with CEO Thomas Ryder, sold 4,500,000 ordinary shares at £2.75 each on September 11, 2026, on the London Stock Exchange. Additionally, Chief Operating Officer Steven Granite also sold 2,500,000 ordinary shares at the same price of £2.75 on the same date and exchange. These transactions represent a significant sale of shares by key personnel within the company.

Disclaimer*

Applied Nutrition PLC
11 September 2026
 

Applied Nutrition plc

Director/PDMR Dealing

 

Applied Nutrition plc (the "Company"), a leading sports nutrition, health and wellness brand, announces the following transactions in the Company's shares. This announcement is made in accordance with Article 19(1) of the EU Market Abuse Regulation as incorporated into UK law through the European Union (Withdrawal) Act 2018.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Ryder Holdings Ltd

2

 

Reason for the notification

 

a)

 

Position/status

 

Person Closely Associated with Thomas Ryder, PDMR / Chief Executive Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Applied Nutrition plc

b)

 

LEI

 

213800KCP1IDX51ZHE47

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of £0.0002 each

Identification code

GB00BPVDXX64



b)

 

Nature of the transaction

 

 

Sale of shares

c)

 

Price(s) and volume(s)







Price

Volume




£2.75

4,500,000







d)

 

Aggregated information




- Aggregated volume

n/a



- Price




e)

 

Date of the transaction

 

 

2026-09-11

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Steven Granite

2

 

Reason for the notification

 

a)

 

Position/status

 

PDMR / Chief Operating Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Applied Nutrition plc

b)

 

LEI

 

213800KCP1IDX51ZHE47

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of £0.0002 each

Identification code

GB00BPVDXX64



b)

 

Nature of the transaction

 

 

Sale of shares

c)

 

Price(s) and volume(s)







Price

Volume




£2.75

2,500,000







d)

 

Aggregated information




- Aggregated volume

n/a



- Price




e)

 

Date of the transaction

 

 

2026-09-11

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

Further information and contacts

Applied Nutrition plc

via Alma

Thomas Ryder, Chief Executive Officer


Steven Granite, Chief Operating Officer


Joe Pollard, Chief Financial Officer


 

Alma Strategic Communications

(Public Relations adviser to Applied Nutrition)

 

+44 (0) 203 405 0205

appliednutrition@almastrategic.com

Rebecca Sanders-Hewett, Sam Modlin, Joe Pederzolli, Sarah Peters

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings